Crohn Disease: Clinical Trials

167 trials for Crohn Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

85 completed, 26 terminated, 16 recruiting, 14 unknown. 167 Phase 1, 66 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1167Completed 85, Terminated 26, Recruiting 16, Unknown 14, Not yet recruiting 10, Withdrawn 10, Active not recruiting 5, Enrolling by invitation 1
Phase 266Completed 27, Terminated 13, Recruiting 10, Unknown 7, Not yet recruiting 4, Withdrawn 4, Active not recruiting 1

Follow Crohn Disease: new trials by email Literature Review of Crohn Disease trials Research Report on Crohn Disease

Trials (filtered) newest first · largest first

All 167 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
Duvakitug - Ulcerative Colitis, Crohn's Disease
Phase 1Not yet recruitingSanofi252026-11-032026-11-06
R-3750 in Patients With Crohn's Disease
R-3750, Placebo - Crohn Disease (CD)
Phase 1Not yet recruitingRise Therapeutics LLC402026-11-012026-08-28
Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants
CM551, Placebo - Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Phase 1Not yet recruitingKeymed Biosciences Co.Ltd482026-10-012026-10-28
Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study
Oxygen Gas for Inhalation, Standard of care - Inflammatory Bowel Disease (IBD), Crohn Disease
Phase 1 / Phase 2Not yet recruitingUniversity of British Columbia542026-09-012026-08-26
A Phase 1 Study of ATORM-C in Patients With Crohn's Disease
Autologous Adult Stem Cell-Derived Intestinal Organoid - Crohn's Diseases, Crohn's Disease
Phase 1RecruitingORGANOIDSCIENCES LTD.182026-09-012026-09-16
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Xylitol, Placebo - Inflammatory Bowel Diseases, Clostridioides Difficile Infection
Phase 1Not yet recruitingBrigham and Women's Hospital992026-08-012026-02-25
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
BDHK-2009 Tablets, Placebo - Ulcerative Colitis (UC), Ulcerative Colitis (Disorder)
Phase 1RecruitingBenethera (Shaoxing) Biotechnology Co., Ltd.682026-05-182026-06-08
Clostridium Butyricum in Stenosing Crohn's Disease
Clostridum Butyricum Capsule, Trehalose - Crohn Disease (CD)
Phase 1 / Phase 2RecruitingSan Giovanni Addolorata Hospital402026-05-082026-09-04
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T - Inflammatory Bowel Diseases (IBD)
Phase 1 / Phase 2Not yet recruitingiCell Gene Therapeutics182026-04-072026-04-22
Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients
injection of CNK-UT009 - Inflamatory Bowel Disease, Crohn Disease (CD)
Phase 1Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine402026-04-012026-02-18
Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
25mg adalimumab-680LT and 15/25 mg risankizumab-800CW, Adalimumab-680LT 25mg, Risankizumab-800CW 15 mg/25 mg - Ulcerative Colitis (UC), Crohn Disease (CD)
Phase 1 / Phase 2Not yet recruitingUniversity Medical Center Groningen302026-01-152026-01-14
Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease
injection of thawed SVF - Crohn Disease (CD)
Phase 1 / Phase 2RecruitingAssistance Publique Hopitaux De Marseille252025-12-302026-06-05
The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients
Vitamin D3 (Cholecalciferol) - Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
Phase 1Active not recruitingTerry Ponich1502025-11-052026-10-05
A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease
PALI-2108 - Fibrostenotic Crohn's Disease
Phase 1Active not recruitingPalisade Bio62025-10-172026-02-23
Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease
CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System, Prednisone/Methylprenisolone, Palifermin - Crohn Disease
Phase 1 / Phase 2Not yet recruitingStanford University142025-07-012025-05-23
Treatment of Moderate to Severe Refractory Crohn's Disease
TRX103, Cyclophosphamide - Crohns Disease
Phase 1 / Phase 2RecruitingTr1X, Inc.392025-05-052025-12-10
Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula
AdMSC (CellReady®) - Crohn Disease
Phase 1 / Phase 2RecruitingUniversity Hospital, Toulouse92025-03-122025-12-24
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
Ustekinumab - Psoriasis, Crohn Disease
Phase 1RecruitingUniversity Medical Center Groningen562025-01-062025-01-15
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
GSK4528287, Placebo - Colitis, Ulcerative
Phase 1Active not recruitingGlaxoSmithKline482024-11-182026-08-26

Showing 20 of 167. Sign in to see all of them.

Narrower conditions

Colitis, Ulcerative (46)  ·  Inflammatory Bowel Diseases (43)  ·  Arthritis, Rheumatoid (8)  ·  Arthritis, Psoriatic (6)  ·  Autoimmune Diseases (6)  ·  Fistula (6)  ·  Inflammation (5)  ·  Rectal Fistula (5)  ·  Spondylitis, Ankylosing (4)  ·  Axial Spondyloarthritis (3)  ·  Psoriasis (3)  ·  Arthritis, Juvenile (2)  ·  Colitis (2)  ·  Colonic Neoplasms (2)

Broader conditions

Gastroenteritis (167)  ·  Digestive System Diseases (166)  ·  Gastrointestinal Diseases (166)  ·  Intestinal Diseases (166)  ·  Inflammatory Bowel Diseases (124)  ·  Colonic Diseases (50)  ·  Colitis (45)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Pathological Conditions, Anatomical (15)  ·  Immune System Diseases (11)  ·  Arthritis (9)  ·  Joint Diseases (9)  ·  Musculoskeletal Diseases (9)  ·  Rectal Diseases (9)  ·  Skin and Connective Tissue Diseases (9)

Interventions

Fecal Microbiota Transplantation (8)  ·  Cyclophosphamide (4)  ·  Ustekinumab (3)  ·  Antilymphocyte Serum (2)  ·  Certolizumab Pegol (2)  ·  Cholecalciferol (2)  ·  Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Infliximab (2)  ·  Melphalan (2)  ·  Mercaptopurine (2)  ·  Mesna (2)  ·  Methylprednisolone (2)  ·  Midazolam (2)  ·  Nivolumab (2)

Sponsors

GlaxoSmithKline (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (6)  ·  AstraZeneca (5)  ·  University Medical Center Groningen (5)  ·  Anthony Lembo (4)  ·  Meir Medical Center (4)  ·  Stanford University (4)  ·  Mayo Clinic (3)  ·  Teva GTC (3)  ·  The Cleveland Clinic (3)  ·  Assistance Publique Hopitaux De Marseille (2)  ·  Direct Biologics, LLC (2)  ·  Janssen Research & Development, LLC (2)  ·  Jiangsu Topcel-KH Pharmaceutical Co., Ltd. (2)  ·  Medtronic - MITG (2)

Countries

United States (74)  ·  Netherlands (15)  ·  Canada (11)  ·  China (11)  ·  Australia (10)  ·  United Kingdom (10)  ·  Belgium (9)  ·  France (8)  ·  Germany (8)  ·  Israel (8)  ·  Spain (7)  ·  Italy (4)  ·  South Korea (4)  ·  Switzerland (4)  ·  Poland (3)

Top investigators

Amy Lightner, MD (6)  ·  Yaron Ilan, MD (3)  ·  Alka Goyal, MD (2)  ·  Bill Arana (2)  ·  David Suskind, MD (2)  ·  David Ziring, MD (2)  ·  Fred Konikoff, professor (2)

Results publications

PMID 17560413, PMID 38580386, PMID 20736987, PMID 23059643, PMID 23648372, PMID 25162366, PMID 25647155, PMID 26116801, PMID 27412883, PMID 27542133, PMID 28349233, PMID 28778448, PMID 28814432, PMID 28847751, PMID 29030361, PMID 29321063, PMID 30710527, PMID 31380382, PMID 31784432, PMID 31792136, PMID 33310655, PMID 33571293, PMID 33599356, PMID 33676969, PMID 34389161, PMID 35262901, PMID 35470301, PMID 36322714, PMID 36732049, PMID 37004656, PMID 37904247, PMID 38365502, PMID 39707077, PMID 39855667, PMID 40254304, PMID 40357993, PMID 41469061, PMID 41895287, PMID 42012633, PMID 42049742, PMID 42334201

NIH funding

2015 (2), 2016 (2), 2017 (2), 1UL1RR025014-01 (1), 2009 (1), 2014 (1), 2018 (1), 2019 (1), 2023 (1), 2025 (1), P50DK083007 (1), R01DK126448 (1), R21AT001628 (1), R21AT002534 (1), UL1RR024150 (1)